Using radiofrequency treatment for menopause-related genitourinary symptoms
Radiofrequency Non-ablative in the Treatment of Genitourinary Syndrome of Menopause
This study tests if a new radiofrequency treatment can help women with menopause-related vaginal and urinary symptoms feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 58 (estimated) |
| Ages | 45 Years to 65 Years |
| Sex | Female |
| Sponsor | Centro de Atenção ao Assoalho Pélvico Academic / other |
| Locations | 1 site (Salvador, Estado de Bahia) |
| Trial ID | NCT03506594 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a non-ablative radiofrequency technique in treating Genitourinary Syndrome of Menopause in women. Participants undergo five sessions of radiofrequency treatment, administered by a trained physical therapist, with assessments including vaginal pH, cell maturation index, and questionnaires to evaluate symptoms. The treatment aims to alleviate symptoms such as vulvovaginal atrophy and urinary tract issues associated with menopause. Each session lasts over 20 minutes and is conducted in a gynecological position.
Who should consider this trial
Good fit: Ideal candidates are women under 65 years of age who are experiencing clinical symptoms of Genitourinary Syndrome of Menopause.
Not a fit: Patients with neurological degenerative diseases, sensory deficits in the genital region, or those using hormone therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for women suffering from menopause-related genitourinary symptoms.
How similar studies have performed: While similar approaches have been explored, this specific application of non-ablative radiofrequency for this condition is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * will be women in menopause until 65 years of age with clinical complaints of Genitourinary Syndrome of Menopause and who agree to voluntarily participate in the research. Exclusion Criteria: * will be excluded from the study participants with limited understanding, with neurological degenerative chronic diseases, sensory deficit in the genital region, users of pacemaker and intrauterine device of cooper and women under hormone therapy under six months
Where this trial is running
Salvador, Estado de Bahia
- Centro de Atenção ao Assoalho Pelvico — Salvador, Estado de Bahia, Brazil (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.